Canada becomes second country to approve Moderna's COVID-19 shot
"After a thorough, independent review of the evidence, it has determined that the Moderna vaccine meets the department's stringent safety, efficacy and quality requirements."
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)ByREUTERS
